IP Library Granted Patent US 10,953,127
Granted Patent B2
US 10,953,127 · App. 13/146,553 · Granted Mar 23, 2021

Absorbent foam wound dressing materials

Inventors: William Pigg (York, GB); Michelle Del Bono (Barnoldswick, GB); Paul Howard Lowing (Keighley, GB)
Assignee: KCI USA, INC.
A61L15/425A61L15/225
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,953,127
App. No.
13/146,553
Granted
Mar 23, 2021
Kind
B2
Abstract

A wound dressing material comprising a solid substrate having interstitial spaces therein, wherein said substrate is a hydrophilic open-cell foam material, and wherein said interstitial spaces are at least partially filled by a hydrophilic polyurethane foam different from said substrate foam material. Also provided is a method of making a porous wound dressing material comprising the steps of: providing a substrate of a solid hydrophilic first foam material; applying a fluid or gel polyurethane foam prepolymer mixture to at least one surface of said solid substrate; and curing said prepolymer in contact with said solid substrate.

Claims (28)

1. A wound dressing material, comprising:

a solid substrate having a plurality of interconnected interstitial spaces therein, wherein said solid substrate is a hydrophilic open-cell foam material; and

a hydrophilic polyurethane foam forms a substantially continuous interstitial foam structure extending between the plurality of interconnected interstitial spaces of said solid substrate.

2. The wound dressing material of claim 1 , wherein said hydrophilic polyurethane foam is applied to one side only of said solid substrate.

3. The wound dressing material of claim 2 , wherein one surface of said wound dressing material consists essentially of said hydrophilic polyurethane foam.

4. A wound dressing comprising the wound dressing material of claim 1 .

5. The wound dressing of claim 4 which is sterile and packaged in a microorganism-impermeable container.

6. The wound dressing material of claim 1 , wherein said solid substrate is elastically compressible and exhibits an elongation at break of at least about 100%.

7. The wound dressing material of claim 1 , comprising from about 10 wt % to about 90 wt % of said hydrophilic polyurethane foam, based on total weight of the wound dressing material.

8. The wound dressing material of claim 1 , wherein said hydrophilic polyurethane foam has a basis weight of from about 0.2 to about 1.5 kg/rn2.

9. The wound dressing material of claim 1 , wherein the interstitial spaces are present in the solid substrate at from about 5 to about 30 pores per cm.

10. A method of making a porous wound dressing material comprising the steps of:

providing a substrate of a solid hydrophilic first foam material having a plurality of interconnected interstitial spaces therein;

applying a fluid or gel polyurethane foam prepolymer mixture to at least one surface of said substrate such that the fluid or gel polyurethane foam prepolymer mixture is distributed within the plurality of interconnected interstitial spaces of said substrate; and

curing said fluid or gel polyurethane foam prepolymer mixture to provide a hydrophilic polyurethane foam that forms a substantially continuous interstitial foam structure extending between the plurality of interconnected interstitial spaces of said substrate.

11. The method of claim 10 , wherein the fluid or gel polyurethane foam prepolymer mixture comprises: 1 part by weight of an isocyanate-capped prepolymer having from about 0.5 to about 1.2 meq NCO groups/g; from about 0.4 to about 1.0 parts by weight of water; and from about 0.05 to about 0.4 parts by weight of a C1 to C3 monohydric alcohol.

12. The method of claim 10 , wherein said step of applying comprises compressing and releasing said substrate in contact with said fluid or gel polyurethane foam prepolymer mixture to increase uptake of the fluid or gel polyurethane foam prepolymer mixture into the substrate.

13. The method of claim 10 , wherein said step of applying comprises: applying a solvent to said substrate, applying a layer of said fluid or gel polyurethane foam prepolymer mixture to said substrate, and allowing the fluid or gel polyurethane foam prepolymer mixture to impregnate the substrate.

14. The method of claim 10 further comprising sterilizing said wound dressing material.

15. The wound dressing material of claim 10 , wherein the interstitial spaces are present in the substrate at from about 5 to about 30 pores per cm.

16. A wound dressing material formed by a method comprising:

providing a substrate of a solid hydrophilic first foam material having a plurality of interconnected interstitial spaces therein;

applying a fluid or gel polyurethane foam prepolymer mixture to at least one surface of said substrate such that the fluid or gel polyurethane foam prepolymer mixture is distributed within the plurality of interconnected interstitial spaces of said substrate; and

curing said fluid or gel polyurethane foam prepolymer mixture to provide a hydrophilic polyurethane foam that forms a substantially continuous interstitial foam structure extending between the plurality of interconnected interstitial spaces of said substrate.

17. The wound dressing material of claim 16 , wherein the fluid or gel polyurethane foam prepolymer mixture comprises: 1 part by weight of an isocyanate-capped prepolymer having from about 0.5 to about 1.2 meq NCO groups/g; from about 0.4 to about 1.0 parts by weight of water; and from about 0.05 to about 0.4 parts by weight of a C1 to C3 monohydric alcohol.

18. The wound dressing material of claim 16 , wherein said step of applying comprises compressing and releasing said substrate in contact with said fluid or gel polyurethane foam prepolymer mixture to increase uptake of the fluid or gel polyurethane foam prepolymer mixture into the substrate.

19. The wound dressing material of claim 16 , wherein said step of applying comprises: applying a solvent to said substrate, applying a layer of said fluid or gel polyurethane foam prepolymer mixture to said substrate, and allowing the fluid or gel polyurethane foam prepolymer mixture to impregnate the substrate.

20. The wound dressing material of claim 10 , wherein the interstitial spaces are present in the substrate at from about 5 to about 30 pores per cm.

Assignments (13)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 6, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; TECHNIMOTION, LLC
Reel/Frame 050945/0278 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2019
From: BANK OF AMERICA, N.A.
To: KCI USA, INC.
Reel/Frame 050710/0955 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
SECURITY AGREEMENT Recorded Feb 7, 2017
From: KCI USA, INC., AS GRANTOR
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041650/0013 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
MERGER AND CHANGE OF NAME Recorded May 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US),INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 035645/0178 →
MERGER AND CHANGE OF NAME Recorded Feb 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 034954/0870 →
SECURITY AGREEMENT Recorded Oct 29, 2013
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 031508/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2011
From: PIGG, WILLIAM; DEL BONO, MICHELLE; LOWING, PAUL HOWARD
To: SYSTAGENIX WOUND MANAGEMENT (US) INC.
Reel/Frame 027364/0148 →
Priority Claims (1)
GB 0901865.6 · Feb 4, 2009 · national
Continuity (1)
Related Publication 20120078154A1 · Mar 29, 2012